Product logins

Find logins to all Clarivate products below.


Spinal Implants | Market Insights | Asia Pacific (Supplemental) | 2021

While the COVID-19 pandemic will significantly impact the spinal implant market in the short term, favorable demographics and increased access to health care in some of the countries covered will ultimately lead to growth in the Asia Pacific spinal implant market through 2029. Although the spinal implant market will be somewhat limited by pricing pressures, challenging reimbursement environments, and protectionist policies, advancements in medical facilities and an increased focus on physician training will supprt overall market expansion.

This Medtech 360 Report provides high-level market metrics for spinal implants in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific region, across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…
Report
Aesthetic Injectables – Market Insights – Asia Pacific
The Asia Pacific aesthetic injectable market will continue to expand through 2034, fueled by continuous innovation and the introduction of differentiated products by leading global and regional…
Report
Sports Medicine Devices – Market Insights – Asia Pacific
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, and improved surgeon training will drive rapid growth in the Asia Pacific…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…